Tag

The London Neurosurgery Partnership is a unique concept in the provision of neurosurgical care. The team comprises eleven Consultant Neurosurgeons, all of whom are recognised superspecialists in their given area of expertise. As a result we can ensure that every patient seen by the group is matched with the Consultant Neurosurgeon best placed by virtue of their training and expertise to deliver the individualised and state of the art care each patient deserves.

Working as a team also ensures that our patients can access high quality neurosurgical care at all times from a consultant who will be familiar with their treatment plan at a location convenient to the patient. When appropriate, advice and treatment can be delivered by the composite team.

The London Neurosurgery Partnership has access to all of the latest neurosurgical technologies including the CyberKnife® and Gamma Knife® for radiosurgery which avoids the use of conventional open surgery in some cases and Minimally Invasive Techniques for both Cranial and Spinal neurosurgery when this is not possible. A key aspect of making use of such cutting edge technologies is the decision making process involved and this, in our opinion, is best done by a group of clinicians who are used to working together as a team to ensure that the latest technology and techniques are used appropriately based on the latest clinical guidelines.

Dr. Nazir Rampersaud is a research fellow at the UCL School of Pharmacy specializing in the development and testing of novel compounds for the treatment of Parkinson's disease. More specifically, Dr. Rampersaud's current research entails examining Exendin-4, a glucagon-like peptide 1 receptor agonist, in the treatment of both motor and nonmotor symptoms of Parkinson pathology. His research has been funded by Parkinson's UK, the Cure Parkinson's Trust, and the Michael J. Fox foundation.